Research Results from Division of Medical Oncology Update Knowledge of Desmoid Tumor (First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor).

The article details a case study on the use of avapritinib for treating sporadic desmoid tumors (DTs), which are rare and often resistant to conventional treatments. Topics discussed include the local aggressiveness of DTs, the limited systemic treatment options, and the partial response of the tumor to avapritinib.